These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 28476121

  • 1. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.
    Velentzis LS, Salagame U, Canfell K.
    BMC Health Serv Res; 2017 May 05; 17(1):326. PubMed ID: 28476121
    [Abstract] [Full Text] [Related]

  • 2. Menopausal hormone therapy and women's health: An umbrella review.
    Zhang GQ, Chen JL, Luo Y, Mathur MB, Anagnostis P, Nurmatov U, Talibov M, Zhang J, Hawrylowicz CM, Lumsden MA, Critchley H, Sheikh A, Lundbäck B, Lässer C, Kankaanranta H, Lee SH, Nwaru BI.
    PLoS Med; 2021 Aug 05; 18(8):e1003731. PubMed ID: 34339416
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of hormone therapy in the United States.
    Lekander I, Borgström F, Ström O, Zethraeus N, Kanis JA.
    J Womens Health (Larchmt); 2009 Oct 05; 18(10):1669-77. PubMed ID: 19857096
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination.
    Wegienka G, Havstad S, Kelsey JL.
    J Womens Health (Larchmt); 2006 May 05; 15(4):369-78. PubMed ID: 16724885
    [Abstract] [Full Text] [Related]

  • 6. What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations.
    Long L, Briscoe S, Cooper C, Hyde C, Crathorne L.
    Health Technol Assess; 2015 Jan 05; 19(8):1-134. PubMed ID: 25629427
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
    Naftolin F, Friedenthal J, Nachtigall R, Nachtigall L.
    F1000Res; 2019 Jan 05; 8():. PubMed ID: 31543950
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
    Harman SM.
    Fertil Steril; 2014 Apr 05; 101(4):887-97. PubMed ID: 24680648
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.
    Crawford SL, Crandall CJ, Derby CA, El Khoudary SR, Waetjen LE, Fischer M, Joffe H.
    Menopause; 2018 Dec 21; 26(6):588-597. PubMed ID: 30586004
    [Abstract] [Full Text] [Related]

  • 12. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
    Rossouw JE, Manson JE, Kaunitz AM, Anderson GL.
    Obstet Gynecol; 2013 Jan 21; 121(1):172-6. PubMed ID: 23262943
    [Abstract] [Full Text] [Related]

  • 13. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
    Trémollieres FA, André G, Letombe B, Barthélemy L, Pichard A, Gelas B, Lopès P.
    Maturitas; 2022 Dec 21; 166():58-64. PubMed ID: 36058119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Menopausal hormone therapy and breast cancer.
    Santen RJ.
    J Steroid Biochem Mol Biol; 2014 Jul 21; 142():52-61. PubMed ID: 23871991
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women's Health Initiative randomized controlled trial.
    Zethraeus N, Borgström F, Jönsson B, Kanis J.
    Int J Technol Assess Health Care; 2005 Jul 21; 21(4):433-41. PubMed ID: 16262965
    [Abstract] [Full Text] [Related]

  • 18. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.
    Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC, Ramsey SD.
    Ann Intern Med; 2014 May 06; 160(9):594-602. PubMed ID: 24798522
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
    Mohan G, Chattopadhyay S.
    JAMA Oncol; 2020 Sep 01; 6(9):1434-1444. PubMed ID: 32556187
    [Abstract] [Full Text] [Related]

  • 20. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.
    Coronado PJ, Gómez A, Iglesias E, Fasero M, Baquedano L, Sánchez S, Ramírez-Polo I, de la Viuda E, Otero B, Llaneza P, Mendoza N, Lubián DM, HMT Eligibility Criteria Group.
    Menopause; 2024 Mar 01; 31(3):234-242. PubMed ID: 38385734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.